A Phase 1b Study Evaluating the Safety and Efficacy of AMG 757 in Combination with AMG 404 in Subjects with Small Cell Lung Cancer (SCLC)

Grants and Contracts Details

StatusActive
Effective start/end date10/4/218/29/25

Funding

  • AMGen: $331,146.00